Parkinson’s Disease

Parkinson’s Disease / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 8428403 |

Jeremy Steinberger, Jeffrey Gilligan, Branko Skovrlj, Christopher A. Sarkiss, Javier Z. Guzman, Samuel K. Cho, John M. Caridi, "The Effect of Parkinson’s Disease on Patients Undergoing Lumbar Spine Surgery", Parkinson’s Disease, vol. 2018, Article ID 8428403, 7 pages, 2018.

The Effect of Parkinson’s Disease on Patients Undergoing Lumbar Spine Surgery

Academic Editor: Giovanni Mirabella
Received14 Jan 2018
Accepted30 May 2018
Published27 Jun 2018


Study Design. Retrospective Database Analysis. Objective. The purpose of this study was to assess characteristics and outcomes of patients with Parkinson’s disease (PD) undergoing lumbar spine surgery for degenerative conditions. Methods. The Nationwide Inpatient Sample was examined from 2002 to 2011. Patients were included for study based on ICD-9-CM procedural codes for lumbar spine surgery and substratified to degenerative diagnoses. Incidence and baseline patient characteristics were determined. Multivariable analysis was performed to determine independent risk factors increasing incidence of lumbar fusion revision in PD patients. Results. PD patients account for 0.9% of all degenerative lumbar procedures. At baseline, PD patients are older (70.7 versus 58.9, ) and more likely to be male (58.6% male, ). Mean length of stay (LOS) was increased in PD patients undergoing lumbar fusion (5.1 days versus 4.0 days, ) and lumbar fusion revision (6.2 days versus 4.8 days, ). Costs were 7.9% () higher for lumbar fusion and 25.2% () higher for lumbar fusion revision in PD patients. Multivariable analysis indicates that osteoporosis, fluid/electrolyte disorders, blood loss anemia, and insurance status are significant independent predictors of lumbar fusion revision in patients with PD. Conclusion. PD patients undergoing lumbar surgery for degenerative conditions have increased LOS and costs when compared to patients without PD.

1. Introduction

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by resting tremors, rigidity, bradykinesia, postural instability, and gait disturbances [1]. The prevalence of PD in industrialized countries is estimated at 0.3% of the entire population with approximately 7 million people affected worldwide [2]. PD is an age-related disease which is rare before the age of 50, with a prevalence of about 1% in people over the age of 60 and up to 4% in people over the age of 80 [3, 4].

Apart from the neurodegenerative symptoms, patients with PD suffer from a wide variety of systemic and musculoskeletal dysfunctions. They are predisposed to falls due to a high incidence of visual impairment and autonomic dysfunction separate from neurodegenerative symptoms [5]. Epidemiologic studies suggest that approximately half of PD patients fall at least once as compared with a third of healthy ambulatory subjects greater than 60 years of age [6, 7]. These patients also suffer from osteoporosis, thus increasing their risk of bone fractures [8]. Musculoskeletal dysfunction in patients with PD leads to an increased incidence of muscle weakness and degenerative spondylarthroses resulting in scoliosis, thoracic kyphosis, and cervical deformity [9].

PD is increasingly recognized as an important cause of spinal disorders requiring surgical intervention [9]. However, spinal procedures can be complicated by underlying osteoporosis and severe musculoskeletal dysfunction in this population.

In this study, we investigate the effect of PD on patients undergoing lumbar spine surgery. The aim of this study is to identify the incidence, trend, risk factors, outcomes, and cost of lumbar spinal surgery for degenerative disease in PD patients.

2. Materials and Methods

The Nationwide Inpatient Sample (NIS) database, under the auspices of the Healthcare Cost and Utilization Project (HCUP) and administered by the Agency for Healthcare Research and Quality, was queried from 2002 to 2011 [10]. The NIS, which comprises a 20% stratified samples of all hospital discharges, is the largest all-payer hospital inpatient database in the US. This sample comprises approximately 8 million hospitalizations, and when sample weights are applied, it comprises approximately 40 million hospitalizations or 96% of all US hospital discharges each year. The NIS data contain patient demographics (e.g., race, age, and gender), hospital characteristics (e.g., teaching status, location, and size), and clinical outcomes (e.g., mortality, costs, and length of stay).

2.1. Sample Selection

PD was identified by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 332.0, which applies Parkinsonism characterized in the following forms: primary, idiopathic, or not otherwise specified. Patients were separated into two cohorts: patients with PD and those without PD. Hospitalizations were selected for the study based on ICD-9-CM procedural codes for lumbar spine procedures and further stratified to include only procedures for degenerative conditions of the lumbar spine. Only patients with hospitalizations that contained all of the demographics and clinical outcome measures were included. Since our search was conducted in this fashion, it is not known the amount of patients who had incomplete data that were excluded. The procedural codes used in this study are outlined in Table 1. Procedures were organized into three groups: lumbar fusion, lumbar fusion revision, and lumbar decompression without fusion.

ICD-9-CM procedural and diagnosis codes

Procedural codes
81.04Dorsal and dorsolumbar fusion, anterior technique
81.05Dorsal or dorsolumbar fusion, posterior technique
81.06Lumbar and lumbosacral fusion, anterior technique
81.07Lumbar and lumbosacral fusion, lateral transverse process technique
81.08Lumbar and lumbosacral fusion, posterior technique
81.34Refusion of dorsal and dorsolumbar spine, anterior technique
81.35Refusion of dorsal and dorsolumbar spine, posterior technique
81.36Refusion of lumbar and lumbosacral spine, anterior technique
81.37Refusion of lumbar and lumbosacral spine, lateral transverse process technique
81.38Refusion of lumbar and lumbosacral spine, posterior technique
03.09Posterior lumbar decompression without fusion

Diagnosis codes
721.3Lumbosacral spondylosis without myelopathy
721.42Lumbar region, spondylogenic compression of lumbar spinal cord
722.1Lumbar intervertebral disc without myelopathy
722.52Lumbar or lumbosacral intervertebral disc
722.73Lumbar region, intervertebral disc disorder with myelopathy
722.83Lumbar region, postlaminectomy syndrome
722.93Lumbar region, other and unspecified disc disorder
724.02Lumbar region, spinal stenosis

ICD-9-CM: International Classification of Diseases, Ninth Edition, Clinical Modification.
2.2. Outcome Measures

Demographic data was analyzed, which included age, pay schedule, gender, race, modified Elixhauser Comorbidity Index, hospital characteristics, and surgical procedure. We chose the Elixhauser index for its ability to adjust for each single comorbidity’s independent association with hospital death and its significant association with short- and long-term mortality as well as burden of diseases [1113]. We have modified the Elixhauser index to exclude the point value of the neurological comorbidity as this includes the ICD-9-CM code for PD when utilizing the validated and updated comorbidity software provided by HCUP.

Perioperative complications were also chosen based on ICD-9-CM diagnosis codes (Supplementary Appendix A). We further analyzed hospitalization outcomes such as length of stay (LOS), costs, and mortality rates. All hospital charges were adjusted for inflation using the US Bureau of Labor statistics’ yearly inflation calculator to represent charges in the year 2011 and converted into costs with the HCUP costs to charge ratio tool [14, 15].

2.3. Data Analysis

Statistical analysis was performed using SAS version 9.3 (SAS Institute, Cary, NC, USA). Chi-squared test was used for analysis of categorical variables and Student’s t-test was used for continuous variables. Analysis took into account the complex survey design of the NIS and procedures such as surveyfreq, surveymeans, and surveylogistic being used for data analysis. Discharge weights, NIS stratum, and cluster (hospital identification) variables were included to correctly estimate variance and to produce national estimates from the stratified sample. Regression modeling for acute complications adjusting for PD, gender, race, hospital bed size, hospital region, and hospital location and modified Elixhauser index was performed to examine odds ratios for complications referencing PD patients to those without PD.

Multivariate analysis was performed to assess factors associated with lumbar fusion revision in the PD patient population. Factors included in multivariate analysis for lumbar fusion revision included the following: osteoporosis, age, race, gender, hospital size, region and location, insurance, and modified Elixhauser index. Two separate multivariate analyses not isolating the PD patient population but including all lumbar patients looked at the role PD +/− 6 osteoporosis had on lumbar fusion revision. These analyses included the same variables as the model isolating the PD patient population. Cochran–Armitage trend test was performed to assess PD trend of prevalence over time in patients undergoing degenerative lumbar spine surgery. Statistical significance was maintained at .

No Institutional Board Review approval was required for this study.

3. Results

A total of 19,211 PD patients underwent elective spine surgery from 2002 to 2011, with the prevalence significantly increasing over time () (Figure 1). Patients with PD were significantly older (70.7 versus 58.9, ) and more likely to be male (58.6% versus 47.1%, ) (Table 2). A greater proportion of PD patients had Medicare than non-PD patients (77.7% versus 41.1%, ) and more PD patients underwent lumbar decompression without fusion and lumbar fusion revision when compared to non-PD patients () (Table 2).

DemographicsNo PDPD value

Mean age58.970.7<0.0001

Age groups<0.0001


 Native American0.290.15


 Lumbar fusion53.9840.56<0.0001
 Lumbar decompression without fusion42.2355.42<0.0001
 Lumbar fusion revision3.794.020.488

Modified Elixhauser index0.320.70<0.0001

PD: Parkinson’s disease.

PD patients undergoing lumbar spine surgery had more comorbidities than those without PD (Table 3). Notably, patients with PD were more likely to have osteoporosis (7.9% versus 4.0%, ) and congestive heart failure (3.6% versus 1.9%, ). Despite the general pattern of greater comorbidities in patients with PD, this did not hold true for chronic pulmonary disease, rheumatoid arthritis, or obesity (Table 3).

ComorbiditiesNo PDPD value

Congestive heart failure1.943.61<0.0001
Valvular heart disease2.864.34<0.0001
Pulmonary circulation disease0.510.870.001
Peripheral vascular disease2.433.120.006
Chronic pulmonary disease13.9910.62<0.0001
Diabetes w/o chronic complications14.8814.220.276
Diabetes w/chronic complications1.542.260.000
Renal failure1.682.390.001
Liver disease0.760.330.002
Peptic ulcer disease0.020.050.160
Acquired immune deficiency syndrome0.030.050.544
Metastatic cancer0.160.160.916
Solid tumor w/o metastasis0.350.76<0.0001
Rheumatoid arthritis2.822.610.438
Weight loss0.380.91<0.0001
Fluid and electrolyte disorders6.158.46<0.0001
Chronic blood loss anemia0.871.010.374
Deficiency anemia6.898.69<0.0001
Alcohol abuse0.920.540.014
Drug abuse0.790.500.041

PD: Parkinson’s disease.

Adjusted regression modeling for postoperative complications showed genitourinary complications’ odds ratio (OR) = 1.5, confidence interval (CI) = 1.5–1.9, ) and postoperative hemorrhage (OR = 1.3, CI = 1.2–1.5, ) as having significantly increased adjusted odds ratios amongst the complications analyzed (Table 4). As seen in Table 5, PD patients have significantly increased LOS with all procedures analyzed. When compared to non-PD patients, costs were significantly increased in lumbar fusion ($29,427 versus $27,272, ) and lumbar fusion revision ($39,885 versus $31,866, ). PD was not found to be associated with increased mortality in patients undergoing lumbar spine surgery (0.13% versus 0.11%, ).

ComplicationsOdds ratioLow 95% CIHigh 95% CI value

Cerebrovascular accident0.490.073.580.484
Respiratory complication0.850.561.290.444
Cardiac complication1.010.721.430.940
Deep venous thrombosis1.760.983.170.061
Peripheral vascular disease1.380.454.310.575
Neurological complication2.030.994.160.052
Genitourinary complication1.471.161.870.001
Postoperative shock1.240.403.870.716
Wound complication0.880.126.470.904
Pulmonary embolism<0.001<0.001<0.001<0.0001
Postoperative infection1.480.902.430.123
Postoperative hemorrhage1.301.161.47<0.0001
Postoperative pneumonia0.390.052.850.354
Myocardial infarction1.160.423.150.778

PD: Parkinson’s disease. Regression modeling adjusting for gender, race, hospital (bed size, region, and location), and modified Elixhauser index—reference for PD patients without PD.

Length of stay (LOS)Costs ($USD)
No PDPD valueNo PDPD value

Lumbar fusion4.005.13<0.0001$27,272$29,427<0.0001
Lumbar decompression3.284.15<0.0001$12,366$12,4690.717
Lumbar fusion revision4.806.24<0.0001$31,866$39,885<0.0001

PD: Parkinson’s disease.

Multivariate analysis performed on the PD patient population identified several independent factors that increase the odds of revision surgery (Table 6). Of note, PD patients with a diagnosis of osteoporosis (OR = 2.0, ) and Medicare (OR = 1.4, ) had increased likelihood of revision. Uninsured patients showed the most dramatic increased likelihood of revision surgery (OR = 9.84, ). Similar multivariate analysis on all patients undergoing degenerative lumbar spine surgery including PD patients also identified osteoporosis (OR = 1.3, CI = 1.2–1.4, ) as having increased odds of revision surgery (Supplementary Appendix B). However, a diagnosis of PD was not an independent risk factor for revision surgery. The combined diagnoses of PD and osteoporosis showed a significantly increased risk for lumbar fusion revision surgery (OR = 1.8, CI = 1.03–3.2, ) (Supplementary Appendix C).

Risk factorOdds ratioLow 95% CIHigh 95% CI value

Native American<0.001<0.001<0.001<0.0001
Small hospital0.920.362.400.953
Medium hospital0.810.491.330.591
Teaching hospital1.400.922.140.118
Urban hospital1.020.432.420.964
Modified Elixhauser index1.010.951.060.856

Race reference: white; hospital reference: large hospital; region reference: northeast; insurance reference: private.

4. Discussion

Adults older than 50 years are projected to be the fastest growing segment of the adult population. It is estimated that by 2050, a third of the American population will be over the age of 55 and 20% will be over 65 [16]. As such, a growing number of patients undergoing treatment for degenerative spinal conditions will have PD.

Despite its increasing disease burden, only six studies investigating spine surgery in the PD population exist presently [9, 1721]. In this combined cohort of only 95 patients, complications were reported in 59% of all cases with 71% of patients achieving successful fusion following index surgery and 45% requiring revision surgery [22]. In patients who underwent decompression surgery alone, 100% required revision multilevel-instrumented fusion [22]. Satisfactory surgical outcome was noted in only 63% of patients [22].

Babat et al. [17] were the first to report on 14 patients with PD who underwent lumbar spine surgery and found an overall reoperation rate of 86% with hardware failure reported in 29% of patients. The authors opined that the primary mechanisms of failure were relentless kyphosis or segmental instability at the operated levels.

Kaspar et al. [19] assessed the postoperative complications in 24 PD patients undergoing all types of spinal surgery and reported a 21% revision rate, including 2 cases of pseudoarthrosis and 2 patients with recurrent stenosis. The authors concluded that symptoms and functional deficits of spinal disease were often masked by PD, which posed difficulties in diagnosis. However, in their series, the complication rates in PD patients were comparable to those in the general population, and it was the authors’ opinion that spine symptoms improved concomitantly with successful surgery, unless the PD symptoms progressed or significant complications ensued.

Moon et al. [9] reported postoperative outcomes in twenty patients with PD undergoing lumbar fusion surgery for degenerative disease. In their series, only one patient (5%) had a satisfactory outcome. The average postoperative visual analog pain scale (VAS, 0 to 100 mm) was 55.2, whereas the mean preoperative VAS was 53.9. Radiological assessment showed successful fusion in 15 (75%) patients. The authors concluded that a poor surgical outcome might be inevitable due to the progressive natural history of PD and that surgical indications in patients with PD and spinal stenosis should be exercised with caution. It was the authors’ opinion that even though implementing the proper surgical intervention is crucial in treating spinal disease in PD patients, the most important factor in the management of PD patients should be medical and/or surgical treatment of PD itself.

In the present study, a total of 19,211 patients with PD underwent elective lumbar spine surgery for degenerative diagnoses. There was an increasing national trend of PD patients undergoing lumbar spine surgery. The overall prevalence of PD is 1.6% in the population over age of 65 years 6 and 3.5% in those over age of 85 years [23] Additionally, PD patients were more often White males, which is in 7 accordance with the current epidemiologic data on PD [2, 2426].

A larger proportion of patients with PD who underwent surgery had Medicare as their insurance (77.7 versus 41.1, ) compared to other patients, a finding which is not surprising given the older age of PD patients. Compared to non-PD patients, those with PD underwent a greater number of noninstrumented, lumbar decompression-only surgeries (55.4 versus 42.2, ). This could be explained by the increased age and greater number of comorbidities in PD patients, forcing surgeons to perform shorter, less complicated, and potentially safer surgeries on these patients.

Of all postoperative complications, only genitourinary (GU) and hemorrhagic complications were found to be significantly increased in the PD population. GU dysfunction predisposes to urinary retention and is one of the most common autonomic disorders in patients with PD, making this patient population increasingly vulnerable to postoperative GU complications [27]. Hypertension is a common perioperative problem in PD patients that has been associated with increased risk of intracerebral hemorrhage in patients undergoing deep brain stimulator implantation [28, 29]. The increased risk for hemorrhagic complications in our study suggest a need for tight perioperative pressure control with an increased role for surgical drains to decrease hemorrhagic complications in PD patients undergoing lumbar spine surgery.

Additionally, we found that PD patients undergoing lumbar spine surgery had greater LOS and hospitalization costs associated with fusion and fusion revision surgery but not lumbar decompression surgery. While a greater percentage of PD patients underwent decompression surgery without fusion, it is important to decipher whether those patients who undergo decompression surgery alone have higher incidence of revision surgery as has been the finding of previously published studies [22].

Multivariate analysis assessing risk factors associated with lumbar revision surgery in PD patients found that insurance status and osteoporosis were associated with revision following the index procedure. In terms of insurance, uninsured patients were found to have a significantly increased odds ratio of revision surgery (OR = 9.84, ). Uninsured patients, secondary to decreased access to healthcare, likely present with advanced PD, multiple untreated comorbidities, and more severe spinal pathology requiring complex procedures with higher failure rates. As was theorized by other authors on this topic, adequate medical and surgical control of PD is of great importance as it may significantly affect postoperative outcomes in patients undergoing spine surgery [9].

Multiple studies have confirmed the association between osteoporosis and PD [30, 31]. This is not only associated with increased age but also with disorders of bone metabolism [32]. This factor is especially aggravated in women, as most women with PD are also postmenopausal [18]. Studies have shown that low bone mineral density values in PD patients are closely correlated with disease severity, increased bone turnover, vitamin D deficiency, and poor nutritional status [3335]. Low vitamin D levels are associated with increased fracture risk, poor musculoskeletal coordination, and poor muscle tone [9]. When taken together, these factors are important reasons for poor surgical outcomes in PD patients.

This study found that a diagnosis of PD was not found to be an independent risk factor for revision lumbar fusion surgery. However, a combined diagnosis of PD and osteoporosis was found to significantly increase the likelihood of lumbar fusion revision surgery. The poor bone quality in osteoporotic individuals together with the severe musculoskeletal dysfunction associated with PD appears to have significant negative effects on the likelihood of a positive spinal fusion outcome in PD patients, a finding which was also emphasized by Moon et al. [9].

5. Conclusion

This study was able to evaluate the characteristics and outcomes of patients with PD undergoing lumbar spine surgery for degenerative conditions using a large national database. PD patients had increased LOS and overall costs but did not have an increased risk of postoperative mortality. PD in itself was not found to be a risk factor for revision lumbar fusion surgery; however, PD and a diagnosis of osteoporosis significantly increased the likelihood of fusion revision. While the national trend in PD patient’s undergoing elective lumbar surgery is rising, surgeons must be aware of the less favorable outcomes of lumbar spine surgery in patients with PD. PD patients should be treated with greater caution than the general population, and adequate medical and surgical control of PD prior to spine surgery may allow for improved diagnosis and better outcomes in this patient population. Though not investigated in this study, future research could inspect if the rate of readmissions and functional outcomes following surgical intervention differs in the PD patient population. As further data are collected to study the various complications associated with PD, more work can be done to establish strategies and protocols to reduce these complications and help optimize the care and outcomes of PD patients.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.


The manuscript was presented as an abstract in “2015 Annual Meeting of AANS/CNS Section on Disorders of the Spine and Peripheral Nerves, Phoenix, Arizona, March 4–7, 2015.”

Conflicts of Interest

Dr. Samuel Cho works as a consultant for Zimmer, Globus, and Metronic.

Supplementary Materials

Perioperative complications were also chosen based on ICD-9-CM diagnosis codes which are shown in Appendix A. Appendix B demonstrates the multivariate analysis on all patients undergoing degenerative lumbar spine surgery, including PD. Appendix C demonstrates the logistic regression with combined diagnoses of PD with other risk factors. (Supplementary Materials)


  1. J. Jankovic, “Etiology and pathogenesis of Parkinson disease,” in UpToDate, H. Hurtig, Ed., UpToDate, Waltham, MA, USA, 2014. View at: Google Scholar
  2. L. M. de Lau and M. M. Breteler, “Epidemiology of Parkinson’s disease,” The Lancet Neurology, vol. 5, no. 6, pp. 525–535, 2006. View at: Publisher Site | Google Scholar
  3. M. C. de Rijk, M. M. Breteler, G. A. Graveland et al., “Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study,” Neurology, vol. 45, no. 12, pp. 2143–2146, 1995. View at: Publisher Site | Google Scholar
  4. S. K. Van den Eeden, C. M. Tanner, A. L. Bernstein et al., “Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity,” American Journal of Epidemiology, vol. 157, no. 11, pp. 1015–1022, 2003. View at: Publisher Site | Google Scholar
  5. M. Pandya, C. S. Kubu, and M. L. Giroux, “Parkinson disease: not just a movement disorder,” Cleveland Clinic Journal of Medicine, vol. 75, no. 12, pp. 856–864, 2008. View at: Publisher Site | Google Scholar
  6. G. W. Paulson, K. Schafer, and B. Hallum, “Avoiding mental changes and falls in older Parkinson’s patients,” Geriatrics, vol. 41, pp. 59–67, 1986. View at: Google Scholar
  7. W. C. Koller, S. Glatt, B. Vetere-Overfield et al., “Falls in Parkinson’s disease,” Clinical Neuropharmacology, vol. 2, pp. 98–105, 1989. View at: Google Scholar
  8. F. van den Bos, A. D. Speelman, M. Samson et al., “Parkinson’s disease and osteoporosis,” Age Ageing, vol. 42, no. 2, pp. 156–162, 2013. View at: Publisher Site | Google Scholar
  9. S. H. Moon, H. M. Lee, H. J. Chun et al., “Surgical outcome of lumbar fusion surgery in patients with Parkinson’s disease,” Journal of Spinal Disorders & Techniques, vol. 25, no. 7, pp. 351–355, 2012. View at: Publisher Site | Google Scholar
  10. HCUP Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), 2002–2011, Agency for Healthcare Research and Quality, Rockville, MD, USA, 2011,
  11. C. van Walraven, P. C. Austin, A. Jennings et al., “A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data,” Medical Care, vol. 47, no. 6, pp. 626–633, 2009. View at: Publisher Site | Google Scholar
  12. A. Elixhauser, C. Steiner, D. R. Harris et al., “Comorbidity measures for use with administrative data,” Medical Care, vol. 36, no. 1, pp. 8–27, 1998. View at: Publisher Site | Google Scholar
  13. M. T. Sharabiani, P. Aylin, and A. Bottle, “A systematic review of comorbidity indices for administrative data,” Medical Care, vol. 50, no. 12, pp. 1109–1118, 2012. View at: Publisher Site | Google Scholar
  14. HCUP Cost-to-Ratio Files (CCR), Healthcare Cost and Utilization Project (HCUP), 2002–2011, Agency for Healthcare Research and Quality, Rockville, MD, USA, 2011.
  15. Bureau of Labor Statistics, CPI Inflation Calculator, Washington, DC, USA, 2014,
  16. Institute for the Ages, Demographic Transition Facts, Sarasota, FL, USA, 2014,
  17. L. B. Babat, R. F. McLain, W. Bingaman, I. Kalfas, P. Young, and C. Rufo-Smith, “Spinal surgery in patients with Parkinson’s disease: construct failure and progressive deformity,” Spine, vol. 29, no. 18, pp. 2006–2012, 2004. View at: Publisher Site | Google Scholar
  18. A. Bourghli, P. Guerin, J. M. Vital et al., “Posterior spinal fusion from T2 to the sacrum for the management of major deformities in patients with Parkinson disease: a retrospective review with analysis of complications,” ournal of Spinal Disorders & Techniques, vol. 25, no. 3, pp. E53–E60, 2012. View at: Publisher Site | Google Scholar
  19. S. Kaspar, L. Riley, D. Cohen, D. Long, J. Kostuik, and H. Hassanzadeh, “Spine surgery in Parkinson’s,” Journal of Bone and Joint Surgery, vol. 87, p. 292, 2005. View at: Google Scholar
  20. H. Koller, F. Acosta, J. Zenner et al., “Spinal surgery in patients with Parkinson’s disease: experiences with the challenges posted by sagittal imbalance and the Parkinson’s spine,” European Spine Journal, vol. 19, no. 10, pp. 1785–1794, 2010. View at: Publisher Site | Google Scholar
  21. P. M. Wadia, G. Tan, R. P. Munhoz, S. H. Fox, S. J. Lewis, and A. E. Lang, “Surgical correction of kyphosis in patients with camptocormia due to Parkinson’s disease: a retrospective evaluation,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 82, no. 4, pp. 364–368, 2011. View at: Publisher Site | Google Scholar
  22. B. Skovrlj, C. A. Sarkiss, J. Z. Guzman, S. K. Cho, and J. M. Caridi, “A literature review of spine surgery outcomes in patients with Parkinson’s disease,” in Proceedings of the Cervical Spine Research Society European Section Annual Meeting, Pamplona, Spain, June 2014. View at: Google Scholar
  23. M. C. deRijk, C. Tzourio, M. M. Breteler et al., “Prevalence of parkinsonism and Parkinson’ disease in Europe; the EUROPARKINSON Collaborative Study. European Community concerted action on the epidemiology of Parkinson’s disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 62, no. 1, pp. 10–15, 1997. View at: Publisher Site | Google Scholar
  24. A. Wright Willis, B. A. Evanoff, M. Lian, S. R. Criswell, and B. A. Racette, “Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries,” Neuroepidemiology, vol. 34, no. 3, pp. 143–151, 2010. View at: Publisher Site | Google Scholar
  25. J. F. Kurtzke and I. D. Goldberg, “Parkinsonism death rates by race, sex, and geography,” Neurology, vol. 38, no. 10, pp. 1558–1561, 1988. View at: Publisher Site | Google Scholar
  26. D. E. Lilienfeld, D. Sekkor, S. Simpson et al., “Parkinsonism death rates by race, sex and geography: a 1980s update,” Neuroepidemiology, vol. 9, no. 5, pp. 243–247, 1990. View at: Publisher Site | Google Scholar
  27. R. Sakakibara, T. Uchiyama, T. Yamanishi, and M. Kishi, “Genitourinary dysfunction in Parkinson’s disease,” Movement Disorders, vol. 25, no. 1, pp. 2–12, 2010. View at: Publisher Site | Google Scholar
  28. R. Khatib, Z. Ebrahim, A. Rezai et al., “Perioperative events during deep brain stimulation: the experience at Cleveland clinic,” Journal of Neurosurgical Anesthesiology, vol. 20, no. 1, pp. 36–40, 2008. View at: Publisher Site | Google Scholar
  29. D. K. Binder, G. M. Rau, and P. A. Starr, “Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders,” Neurosurgery, vol. 56, no. 4, pp. 722–732, 2005. View at: Publisher Site | Google Scholar
  30. C. H. Kao, C. C. Chen, S. J. Wang, L. G. Chia, and S. H. Yeh, “Bone mineral density in patients with Parkinson’s disease measured by dual photon absorptimetry,” Nuclear Medicine Communications, vol. 15, no. 3, pp. 172–177, 1994. View at: Publisher Site | Google Scholar
  31. F. Ishizaki, T. Harada, S. Katayama, H. Abe, and S. Nakamura, “Relationship between osteopenia and clinical characteristics of Parkinson’s disease,” Movement Disorders, vol. 8, no. 4, pp. 507–511, 1993. View at: Publisher Site | Google Scholar
  32. Y. Sato, M. Kikuyama, and K. Oizumi, “High prevalence of vitamin D deficiency and reduced bone mass in Parkinson’s disease,” Neurology, vol. 49, no. 5, pp. 1273–1278, 1997. View at: Publisher Site | Google Scholar
  33. N. Vaserman, “Parkinson’s disease and osteoporosis,” Joint Bone Spine, vol. 72, no. 6, pp. 484–488, 2005. View at: Publisher Site | Google Scholar
  34. H. Taggart and V. Crawford, “Reduced bone density of the hip in elderly patients with Parkinson’s disease,” Age Ageing, vol. 24, no. 4, pp. 326–328, 1995. View at: Publisher Site | Google Scholar
  35. J. M. Sheard, S. Ash, P. A. Silburn, and G. K. Kerr, “Prevalence of malnutrition in Parkinson’s disease: a systematic review,” Nutrition Reviews, vol. 69, no. 9, pp. 520–532, 2011. View at: Publisher Site | Google Scholar

Copyright © 2018 Jeremy Steinberger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.